AUIYX
Price
$36.06
Change
+$0.14 (+0.39%)
Updated
Jul 25 closing price
Net Assets
640.41M
RMEBX
Price
$60.75
Change
+$0.28 (+0.46%)
Updated
Jul 25 closing price
Net Assets
110.54B
Interact to see
Advertisement

AUIYX vs RMEBX

Header iconAUIYX vs RMEBX Comparison
Open Charts AUIYX vs RMEBXBanner chart's image
AB Equity Income Advisor
Price$36.06
Change+$0.14 (+0.39%)
VolumeN/A
Net Assets640.41M
American Funds American Mutual R2E
Price$60.75
Change+$0.28 (+0.46%)
VolumeN/A
Net Assets110.54B
AUIYX vs RMEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AUIYX vs. RMEBX commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUIYX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 111B vs. AUIYX (640M). AUIYX pays higher dividends than RMEBX: AUIYX (1.40) vs RMEBX (1.12). AUIYX was incepted earlier than RMEBX: AUIYX (29 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than AUIYX (0.65). AUIYX is a more actively managed with annual turnover of: 42.00 vs. RMEBX (31.00). AUIYX has a lower initial minimum investment than RMEBX: AUIYX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : 11.26 vs. AUIYX (7.85). RMEBX return over 5 years is better than : 59.35 vs. AUIYX (52.50).
AUIYXRMEBXAUIYX / RMEBX
Total Expense Ratio0.651.0761%
Annual Report Gross Expense Ratio0.651.0761%
Fund Existence29 years11 years-
Gain YTD11.05511.25398%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets640M111B1%
Annual Yield % from dividends1.401.12125%
Returns for 1 year7.8511.2670%
Returns for 3 years38.0830.31126%
Returns for 5 years52.5059.3588%
Returns for 10 years58.6980.1773%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ONCO4.150.54
+14.96%
Onconetix Inc
ITOS10.170.02
+0.20%
iTeos Therapeutics
CRT9.53-0.01
-0.10%
Cross Timbers Royalty Trust
WTRG37.10-0.07
-0.19%
Essential Utilities
NEO6.29-0.13
-2.02%
NeoGenomics